Cancer predisposition in diabetics: Risk factors considered for predictive diagnostics and targeted Preventive measures

被引:15
作者
Cebioglu M. [1 ]
Schild H.H. [1 ]
Golubnitschaja O. [1 ]
机构
[1] Division of Molecular/Experimental Radiology, Department of Radiology, Rheinische Friedrich-Wilhelms-University of Bonn, 53105 Bonn
关键词
Advanced technologies; Cancer in diabetes; Preventive diagnostics; Prognostic risk factors; Stress/viral etiology; Targeted preventive measures;
D O I
10.1007/s13167-010-0015-4
中图分类号
学科分类号
摘要
Diabetes mellitus (DM) is a lifelong progressive disease with high morbidity and mortality worldwide. Whereas cardiovascular complications are well-known for DM, increasing evidence indicates that diabetics are predisposed to cancer. Understanding of molecular pathomechanisms of cancer in DM is of great importance. Dysregulation of glucose/insulin homeostasis leads to increased production of Reactive Oxygen/Nitrogen Species (ROS/RNS) and consequent damage to chromosomal/ mitochondrial DNA, a frequent finding in DM. Long-term accumulation of modified/damaged DNA is wellacknowledged as triggering cancer. DNA-repair is a highly energy consuming process provoking increased mitochondrial activity. Particularly dangerous is a provoked activity of damaged mitochondria leading to a "vicious circle" lowering energy supply and potentiating ROS/RNS production. Mitochondrial dysfunction may be implicated in pathomechanisms of diabetes-related cancer. High risk for infectious disorders and induced viral proto-oncogenic activity may further contribute to cancer provocation. Much attention should be focused on preventive measures in diabetic healthcare, in order to restrict severe diabetesrelated complications. © European Association for Predictive, Preventive and Personalised Medicine 2010.
引用
收藏
页码:130 / 137
页数:7
相关论文
共 88 条
[1]  
Mozaffari M.S., Abdelsayed R., Schaffer S.W., Diabetic Complications: Pathogenic Mechanisms and Prognostic Indicators, (2009)
[2]  
Larsson S.C., Mantzoros C.S., Wolk A., Diabetes mellitus and risk of breast cancer: A meta-analysis, Int J Cancer, 121, pp. 856-862, (2007)
[3]  
Friberg E., Orsini N., Mantzoros C.S., Et al., Diabetes mellitus and risk of endometrial cancer: A meta-analysis, Diabetologia, 50, pp. 1365-1374, (2007)
[4]  
Larsson S.C., Orsini N., Wolk A., Diabetes mellitus and risk of colorectal cancer: A meta-analysis, J Natl Cancer Inst, 97, pp. 1679-1687, (2005)
[5]  
Wang F., Gupta S., Holly E.A., Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California, Cancer Epidemiol Biomark Prev, 15, pp. 1458-1463, (2006)
[6]  
Adami H.O., McLaughlin J., Ekbom A., Et al., Cancer risk in patients with diabetes mellitus, Cancer Causes Control, 2, pp. 307-314, (1991)
[7]  
Inoue M., Iwasaki M., Otani T., Et al., Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan, Arch Intern Med, 166, pp. 1871-1877, (2006)
[8]  
Zendehdel K., Nyren O., Ostenson C.G., Et al., Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden, J Natl Cancer Inst, 95, pp. 1797-1800, (2003)
[9]  
Verlato G., Zoppini G., Bonora E., Et al., Mortality from site-specific malignancies in type 2 diabetic patients from Verona, Diabetes Care, 26, pp. 1047-1051, (2003)
[10]  
Kowluru R.A., Chan P.S., Oxidative stress and diabetic retinopathy, Exp Diabetes Res. 2007, (2007)